chrisvoncsefalvay/vaers-outcomes huggingface dataset:
allergic to whatever is in a vaccine; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for immunization. Medical history included hereditary angioedema. The patient's concomitant medications were not reported. The nurse stated "Oh yes, Prevnar 13, I am allergic to whatever is in a vaccine there are some components in a vaccine that I am allergic to". As to other medical conditions, she stated that she had what they call hereditary angioedema because of something that was in flu vaccine and the pneumonia vaccine so she have not had any vaccine since 2016. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Temperature 101F, difficult to arouse with some questionable "shaking or seizure" per father's report. Approximately 10 hours after immunization.
p/vax pt had hives & rash, itchy;rash over trunk & extremities;
Member was administered two immunizations on 26 MAR 2010 as part of a mobilization process. Became ill HA and vomiting 27 MAR. Ill until seeking care 3/29. Eval'd in E.R. 3/30. Discharged. SIQ, light duty, continued ill, skin lesions appeared 3/30. Cat Scan 4/8=hemorrhagic intracranial lesions. Admitted.
Left arm pain and swelling.  Myalgias in the arm.  No lumps in axilla.  Subjective fever.  Pain on palpation over local area.  No adenopathy.  Tx - Axid 150 bid, Zyrtec 10 mg qd x 4 days.  If not improved, return and may treat w/ prednisone
Has developed one large hive at site of injection. Reports onset was this morning. The affected area is approximately 2 inches in diameter and is much warmer than the surrounding skin to the touch.  Reports of "itchiness" being the foremost complaint.   Given PO Benadryl 25mg. Given instructions to follow up if there are any changes.
Information has been received from a physician concerning a 12 month old male with no pertinent medical history and no drug reactions or allergies who on 25-FEB-2009 was vaccinated with the first dose of MMR II, albumin status rHA, (lot # not reported), 0.5 mL, subcutaneous. On 13-MAR-2009 the patient was diagnosed with right-sided mumps. The physician did not anticipate prescribing any treatment at the time of the report. The patient sought medical attention at the physician's office. The patient had not recovered. Additional information has been requested.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No concomitant medication was reported. No treatment medication was reported.  This case pertains to the 100 patient of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
The patient was scheduled for a well-child visit along with two other siblings 9 months and 2 y.o. Vaccines drawn up correctly for the patient and double-checked for accuracy with a second RN. At the time of administration the immunizations intended for 9 mo female sibling were administered to the patient. Patient received 0.5 ml Pentacel, 0.5 ml Pneumococcal-13 and 0.25 ml Influenza.   No adverse reaction noted at time of administration. Error immediately reported to the nurse practitioner examining the patients, who then spoke with the mother of the child/patient.
Pregnant, due date April 30th. No issues at all and heartbeat had already been detected 9/10. Received vaccine 9/14 and on 9/24 ultrasound showed baby had stopped developing a week prior.
I don't know if this is related to the Pfizer vaccine but on September 1st (5 months after vaccination)I started having tinnitus in both ears. I have visited my doctor and an audiologist about this. This tinnitus has not gone away. Also at about the same time my sense of smell became heightened so that I keep smelling scents that are gone such as toast in the morning that I smell for several hours after. Also smell things that aren't there at all.
1/13/2020  1130am at daycare vomiting. After he came from daycare he had a few episodes of vomiting and was more tired. No fever. Slight decreased po intake and urinated well.  No abd pain.At 12midnight 1/14/2020 he started with bloody stool filled the diaper-.1/14/2020 Mother took him to the ER. and He was transferred to Hospital barium enema showed - intusseption could not be reduced radiologically so he was taken for surgery. Partial colon resection and terminal ileum removal and appendectomy. Colostomy placed. Hospitalized in ICU and floor from 1/14/2020-1/25/2020. PO feeds started on POD 7. In the future surgeon plans to reverse colostomy.
Information has been received from a pharmacist via company representative referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX (lot number, dose and route were unknown). The pharmacist stated there was no record of the patient receiving ZOSTAVAX in his pharmacy. On an unknown date, one year later the vaccination, the patient developed shingles. The outcome and causality of the event was unknown. Additional information has been requested.
This spontaneous report as received from medical assistant refers to an unspecified patient of unknown age. No medical history and concurrent conditions were reported. On an unknown date, the patient was vaccinated with PROQUAD (Merck) (lot number: L005293 and expiry date: 17-AUG-2016) (dose and route of administration was not reported) which was also exposed to a supported temperature excursion of 17 Fahrenheit (F) for 8 hours and it was administered to unspecified patient after this temperature excursion occurred (incorrect drug storage). No concomitant medications were reported. No adverse effects reported. The outcome of incorrect drug storage was unknown. The reporter considered incorrect product storage to be not related to PROQUAD (Merck). No product quality complaint (PQC) was filed. No further information provided. This is one of the several reports of the same reporter. Additional information has been requested.
received vaccination on 1/10/21 on 1/11/21 developed bright red rash with swelling and arm soreness.  All symptoms started to go away on 1/13/21.  On 1/16/21 injection site on left arm became very itchy and bright red rash appeared again.  Site was swollen and arm pain was worse than first time.  Not debilitating but my shoulder and elbow were sore this time.  On 1/22 rash is not as red but still there.  Arm soreness is still there also
Kinrix vaccine in an unknown thigh; cellulitis; This case was reported by a other health professional via sales rep and described the occurrence of cellulitis in a patient who received DTPa-IPV (Kinrix) (batch number D24G7, expiry date 4th June 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th July 2021, the patient received Kinrix (intramuscular) and Kinrix Pre-Filled Syringe Device. On 12th July 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced vaccine administered at inappropriate site. In July 2021, the patient experienced cellulitis (serious criteria GSK medically significant). On an unknown date, the outcome of the cellulitis and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the cellulitis to be related to Kinrix and Kinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The pediatric patient received Kinrix in an unknown thigh which led to vaccine administered at inappropriate site.  Less than a week after receiving Kinrix, the patient developed cellulitis.  The reporter consented to follow up. The reporter and healthcare professional gave permission to contact them for further information. No other information was shared. This was 1 of 4 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR154891:Same reporter US-GLAXOSMITHKLINE-US2021153977:Same reporter US-GLAXOSMITHKLINE-US2021AMR154892:same reporter
This spontaneous prospective pregnancy report as received from a nurse refers to a female patient of unknown age. No medical history and current conditions were reported. On 10-FEB-2015, the patient at her six to eight weeks gestation, was vaccinated with VARIVAX (Merck) dose 1, 0.5 ml, subcutaneous and with M-M-R II (0.5 ml, dose 1, subcutaneous) on the same day. The Last menstrual period (LMP) and estimated date of delivery (EDD) are not reported. No lab data was reported. Patient sought medical attention, called to the physician's office. The outcome of exposure during pregnancy was unknown. Pregnancy outcome was pending. No further information was provided. Additional information has been requested.
lowblood pressure; dizzy when getting up and lying down for past 10 days; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-May-2021 and was forwarded to Moderna on 24-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (lowblood pressure) and DIZZINESS (dizzy when getting up and lying down for past 10 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOTENSION (lowblood pressure) and DIZZINESS (dizzy when getting up and lying down for past 10 days). At the time of the report, HYPOTENSION (lowblood pressure) and DIZZINESS (dizzy when getting up and lying down for past 10 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.  The patient reported via chatbot that patient had a vaccine in January and patient wanted to know if there was connection between low blood pressure and the vaccine. The patient reported that patient started feeling dizzy when getting up and lying down for past 10 days. Patient have not experienced before. No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.
Very sore left arm since shot. It has not gone away. Pain wakes him up at night. Pain is located over left deltoid. It does not radiate. Is not associated with loss of function or numbness.
fever 101; nausea; body aches and pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101), NAUSEA (nausea) and MYALGIA (body aches and pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (fever 101), NAUSEA (nausea) and MYALGIA (body aches and pain). At the time of the report, PYREXIA (fever 101), NAUSEA (nausea) and MYALGIA (body aches and pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
2/18/21 time around 9pm, sore arm along with red rash, still remains today but better.  Had this reaction 1st vaccine 1/18/21 Moderna Lot #011620A. 2/19/21 body soreness, hands hurt, general not feeling well. 2/20/21 Awake at 2:00 am fever, dizziness, unable to walk straight and passed out. Slight temp w/tingling and numbness in both arms from mid shoulder to fingertips. Vison blurred and wavy. Rested all day.  Today, 2/21/21 felt better at 8:00, vision better and tingling & numbness gone in arms. Foggy head, unable to focus on numbers. Resting but having to do chores for work week tomorrow. Vision still not 100%.
23MAR93 pt devel numbness of rt side of face below cheekbone, around lips & rt eye felt funny dx w/Bell's palsy on 24MAR93;
During Dialysis I started feeling cold. I started getting colder and couldn't warm up. Then, I started vomiting. I called the on-call nurse, and she told me to go to the Emergency Room because she suspected blood poisoning. I went to the Emergency Room and the blood cultures came back negative, but I tested positive for COVID-19. On 2/18/23, I was seeing my Cardiologist and they did an Ultrasound and they told me I had something suspicious on my heart. The asked me to have more blood cultures done. They results came back positive, so I had to go to the Emergency Room and spent 10 days in the hospital.
Diagnosed with Bells Palsy; This is a spontaneous report from a contactable consumer (patient).   A 45-year-old male patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 13Apr2021 15:00 (Lot Number: ER8737) as single dose for covid-19 immunisation.  Medical history included ongoing high blood pressure. There were no known allergies. Concomitant medications included omeprazole; tizanidine; meloxicam and metoprolol all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient was diagnosed with bells palsy on 26Apr2021 08:00 with outcome of recovering. The event resulted in Doctor or other healthcare professional office/clinic visit.
Information has been received from a physician concerning a 22 year old male who on 25-APR-1991 was vaccinated with a first dose of MMR II (route, site and lot number not reported). On 31-JAN-1992, the patient was vaccinated with a second dose of MMR II  (route, site and lot number not reported). On an unknown date, the patient experienced mumps. The outcome for mumps was not reported. Follow up information has been received from the physician who reported that the 18 year old patient at onset date experienced mumps on 22-Dec-2009 and was diagnosed on 24-Dec-2009. The patient experienced right parotitis. The patient's temperature was 100.2 degrees F. A blood work was performed (results not provided). This is one of several reports from the same source. No further information is available.
pain in arm; Headache; body aches; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In July 2022, the patient received the 1st dose of Shingles vaccine. In July 2022, less than a week after receiving Shingles vaccine, the patient experienced pain in arm, headache and general body pain. On an unknown date, the outcome of the pain in arm, headache and general body pain were unknown.   It was unknown if the reporter considered the pain in arm, headache and general body pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-July-2022 Reporter's comment: This case was reported by consumer via interactive digital media. The patient just had his/her shingles shot two days before date of reporting. The side effects were pain in arm, headache and body ache but that certainly was better than the alternative. The patient's insurance paid 100 percent. The follow up would not be possible as contact details were not provided.
dizzy, nausea,  high heart rate, sore arm, fatigue. symptoms lasted about 4 hours
red area warm to touch first appearing 8 days after vaccine, doctor diagnosed as cellulitis/allergic reaction to COVID-19 vaccine. Was prescribed medrol dose pack and clindymiacin
15 lesions over neck, face, right ear and left distal forearm. Scabbed, healing, papular lesions some w/ yellow, crusted discharge.
Patient is fully vaccinated and boosted on 10/22/2021.  Hospitalized on 12/20/2021 and tested + for COVID on this date. Admission diagnoses:  COVID 19, acute respiratory failure, hyoxia, sepsis, elevated troponin, bilateral pneymonia, altered mental status. Labs:  hg 6.9 requiring blood transfusions. low Platetlets 123. elevated D dimer 1,656. Treatment: Lovenox, antibiotcs, remdesivir, barcitinitb and decadron. Patient discharged
This case was reported by a physician via call center representative and described the occurrence of swelling of wrists in a 65-year-old female patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling of wrists and wrist pain. On an unknown date, the outcome of the swelling of wrists and wrist pain were recovered/resolved. It was unknown if the reporter considered the swelling of wrists and wrist pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported however; it could be 64 or 65 years. In 2018, the patient developed swelling down to her wrist, and it was super painful. The symptoms lasted about a week. The reporter stated that, this was getting old when being asked adverse event questions. The reporter declined to provide more information other than what was in the report.
Patient felt extreme pain at time of vaccine administration. The arm continued to be very painful, swollen and red for 3-5 days. The arm is still painful three weeks later. She experiences a burning sensation when lifting the arm and feels like there is a knot in the muscle
This spontaneous report as received from a registered pharmacist refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot # not reported). The pharmacist reported that the patient was administered a dose of ZOSTAVAX in the wrong location of the arm, on the back of the patient's arm, about 2 inches from her elbow. The pharmacist reported that the patient went into the pharmacy and it looked like the dose was not administered deep enough into the patient's skin because it appeared that the vaccine was pooled underneath the skin around the injection site. The pharmacist reported that the patient was experiencing pain and redness at the site. At the time of the report, the patient had not recovered. Additional information has been requested.
Patient received HPV vaccine, then had episode of syncope 10 minutes later. Patient recovered and was able to leave 30 minutes later w/mom. Patient is "frequent fainter" per Mom.
Client received varicella shot in 1998. Developed sxs (mild) 5/06 NO fever and LSO pox.
Patient says she is having a numbness and tingling down her arm and to her middle finger some of the time. I gave her the shot in the lower C form on her left deltoid. She stated she had fallen the day before but on her knees, may be sore. She had a nodule at injection but it has gone away. She will call her MD. She called her MD.
Patient reported arm soreness and redness, along with general fatigue / fever / chills the day after the vaccination.  She present to an urgent care center three days later with continued arm redness and was diagnosed with cellulitis and given Ibuprofen and Augmentin.  Two days after that she developed mouth/lip sores and was prescribed Valtex after again reporting to the urgent care center.
After vaccine he reported being nauseous and dizzy. He got very pale and about 5 minutes after the vaccine he passed out. He came back after about a minute. EMT was called to check patient. Vitals were stable.
Sore arm; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  The patient experienced sore arm  on an unspecified date. Outcome of the event was unknown.   Information on lot/batch number has been requested.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown ages and genders. No medical history or concurrent conditions were reported. On 20-OCT-2015, the patients were vaccinated with ZOSTAVAX, with lot # L028279 and expiration date as 28-OCT-2016 (dosage, frequency and route of administration were not reported). No concomitant therapies were reported. On 21-OCT-2015, a days after onset of therapy both the patients experienced injection site reactions. The outcome of injection site reaction was unknown. No causal relationship was provided between the events and therapy with ZOSTAVAX. This is one of the several reports from the same source. Additional information has been requested.
PATIENT HAS RECEIVED BOTH COVID PFIZER VACCINE DOSES.  PATIENT WAS TESTED ON 8/12/21 AND TESTED POSITIVE TO COVID.
Diarrhea half hour following shot, 2hours following shot, 8 hours following shot into next morning & afternoon following shot.  Vomiting/Nausea hour following shot and following eating breakfast next morning.  Tiredness & Body Aches one to 4 hours following shot.  Next morning 1/24/21 sharp  stabbing  pain  on both sides of upper back area upon standing upright.
Extreme arm soreness, very tired, fever, headache, body aches .  This is the second day after the shot and I still feel bad.
While in waiting area after being given vaccine, felt tingly in head and over body within 3 minutes. Dizzy. Started getting black spots in vision/tunnel vision. Heart pounding and sweating. On verge of fainting. Drank some water and symptoms disappeared within 10 minutes. Did not lose conciousness